K. Nakamura et al.
Bull. Chem. Soc. Jpn. Vol. 79, No. 11 (2006) 1779
the solution. The mixture was stirred for 4 h under Ar at room tem-
perature. A saturated aq solution of NaHCO3 (30 mL) was then
added. The solution was concentrated in vacuo, and the product
was extracted with EtOAc (200 mL) from the solution. The organ-
ic layer was successively washed with a saturated aq solution of
NaHCO3 (50 mL ꢁ 2) and brine (20 mL), and the extract was
dried over Na2SO4. The organic layer was concentrated in vacuo.
The crude product (4.65 g) was chromatographed over silica gel
using a mixture of methanol and chloroform (5:95, v=v) to yield
the product (2.51 g, 79%) as a white solid after evaporating the
eluent. An aliquot of the product was dissolved in dioxane, and
a 1 M HCl solution in dioxane, followed by ether, was added. The
crystals were subjected to analysis: mp 96.8–98.5 ꢃC; 1H NMR
(CDCl3) ꢁ 1.19 (d, 3H, J ¼ 6:9 Hz, –CH(CH3)–), 3.01 (d, 1H, J ¼
13:0 Hz, –CHH–NH2–), 3.08 (d, 1H, J ¼ 13:0 Hz, –CHH–NH2–),
3.19 (q, 1H, J ¼ 6:9 Hz, –CH(CH3)–CO), 3.38 (s, 3H, –COOCH3),
3.68 (s, 3H, –OCH3), 3.87 (s, 3H, –OCH3), 6.63 (s, 1H), 6.81 (s,
1H), 7.20–7.30 (m, 15H); 13C NMR (CDCl3) ꢁ 18.2, 49.2, 51.7,
55.5, 55.8, 56.0, 70.8, 112.0, 118.7, 123.5, 126.8, 127.5, 130.2,
138.9, 144.3, 147.1, 149.8, 175.9; ESI-MS m=z 527.8, calcd for
C32H34NO4S: ðM þ HÞþ, 528.2; Anal. Found: C, 72.80; H, 6.41;
N, 2.62%, calcd for C32H34ClNO4S: C, 72.84; H, 6.30; N, 2.65%.
Fmoc–Gly(1-13C)–D,L-(4,5-Dimethoxy-2-tritylthiobenzyl)-
Ala–OMe (7). To a solution of Fmoc–Gly(1-13C)–OH (58.5 mg,
0.196 mmol) and HBTU (69.3 mg, 0.183 mmol) in DMF (500 mL),
DIEA (66.0 mL, 0.380 mmol) was added, and the solution was
stirred for 5 min. Compound 6 (51.5 mg, 0.0976 mmol) was added
to the reaction mixture, followed by stirring for 17 h under an Ar
atmosphere. The solution was concentrated in vacuo. The solid
residue was dissolved in EtOAc (50 mL), and the organic layer
was successively washed with 5% aq citric acid (20 mL ꢁ 2),
sat. aq NaHCO3 (20 mL ꢁ 2), and brine (5 mL), and dried over
Na2SO4. The filtrate was concentrated in vacuo to give a crude
product (118 mg). The crude material was purified by silica-gel
column chromatography using a mixture of hexane:EtOAc (70:30,
v=v) as an eluent to yield 57.8 mg (73%) of 13C-labeled compound
7 as a white solid: ESI-MS, m=z 830.1, calcd for C4813CH46N2-
NaO7S: ðM þ NaÞþ, 830.3.
11 as a white solid: ESI-MS, m=z 816.6, calcd for C4713CH44N2-
NaO7S: ðM þ NaÞþ, 816.3.
Val–Ala–Val–Phe–Val–Gly(1-13C)–D,L-(Dmmb)Ala–NH2 (13).
Fmoc–NH–SAL–PEG resin (0.26 mmol gꢂ1, 385 mg, 0.10 mmol)
was washed with NMP (2 min ꢁ 3), treated with 20% piperidine
in NMP (v=v) (5 min ꢁ 2, 10 min ꢁ 1) and washed with NMP
(1 min ꢁ 5). The resin was mixed with a solution, which was pre-
pared by mixing dipeptide 11 (83 mg, 0.11 mmol), HBTU (38 mg,
0.10 mmol), HOBt H2O (16 mg, 0.11 mmol), and DIEA (36 mL,
ꢄ
0.21 mmol) in DMF, for 17 h. The obtained resin, Fmoc–Gly-
(1-13C)–D,L-[Dmmb(Trt)]Ala–NH–SAL–PEG resin, was washed
with NMP (1 min ꢁ 5), treated with 10% Ac2O, 5% DIEA in
NMP (v=v), and washed with NMP (1 min ꢁ 3). Then, the peptide
chain elongation was carried out on a model 433A peptide synthe-
sizer (Applied Biosystems, Inc.) using the FastMoc 0.25 mmol
MonPrevPk protocol with end capping with acetic anhydride/
HOBt/DIEA. The amino acids were introduced by a double cou-
pling protocol. After completion of the peptide elongation, the
peptide resin was extensively washed with methanol and dried
in vacuo to give 448 mg of peptide resin 12.
An aliquot of peptide resin 12 (101 mg) was stirred with
Reagent B for 2 h. Ether was added to the reaction mixture, fol-
lowed by stirring for 1 h. The resulting precipitate was washed
with ether three times and then dissolved in 50% aq acetonitrile.
The solution was passed through a disposable ODS cartridge,
and the eluted solution was lyophilized to give a white powder
(18 mg). This compound was purified by RP-HPLC (column:
Cosmosil 5C18-AR-II (10 ꢁ 250 mm)) to give Val–Ala–Val–
Phe–Val–Gly(1-13C)–D,L-(Dmmb)Ala–NH2 (13) (18% based on
Fmoc–NH–SAL–PEG resin); ESI-MS, m=z 844.4, calcd for
C4013CH63N8O9S: ðM þ HÞþ, 844.4; amino acid analysis: Gly1-
Ala1:1Val3:2Phe1:3
.
Val–Ala–Val–Phe–Val–Gly(1-13C)–SCH2CH2SO3H
(15).
Peptide 13 (0.5 mg) was treated with a 200 mL of a TFA solution
containing 0.5% TCEP (v=w) by stirring for 30 h. The reaction
mixture was injected directly onto an RP-HPLC (column: YMC-
PACK ProC18 (4:6 ꢁ 150 mm)). After the addition of sodium 2-
mercaptoethanesulfonate (1 mg, excess) to the fraction at 18.9 min
(Fig. 9), the mixture was freeze-dried to give white powder. The
powder was dissolved in 100 mL of a mixture of 0.2 M sodium
phosphate buffer (pH 7.8) and acetonitrile (1:1, v=v), and the
reaction mixture was stirred for 2 h and subjected to RP-HPLC
to isolate the product, peptide thioester 15; ESI-MS, m=z 716.3,
calcd for C3013CH51N6O9S2: ðM þ HÞþ, 716.3.
Fmoc–Gly(1-13C)–D,L-(4,5-Dimethoxy-2-mercaptobenzyl)-
Ala–OMe (8). To a solution of 7 (40.5 mg, 50.1 mmol) in DCM
(200 mL), triisopropylsilane (51.3 mL, 250 mmol) and TFA (200
mL) were added. The reaction mixture was stirred at room temper-
ature for 1 h and then concentrated in vacuo. The product was
isolated by RP-HPLC (column: Cosmosil 5C18-AR-II (20 ꢁ 250
mm)) and lyophilized to give 12.9 mg (46%) of 8 as a whþite solid:
ESI-MS, m=z 566.2, calcd for C2913CH33N2O7S: ðM þ HÞ , 566.2.
Fmoc–Gly(1-13C)–D,L-(4,5-Dimethoxy-2-tritylthiobenzyl)-
Ala–OH (11). To a stirred ice cold solution of 7 (619 mg, 0.766
mmol) in THF (15 mL), 0.5 M aq solution of lithium hydroxide
(1.53 mL, 0.765 mmol) was added dropwise over 30 min. The re-
action mixture was stirred for 30 min, and a 0.5 M aq solution of
lithium hydroxide (0.770 mL, 0.385 mmol) was then added drop-
wise to the reaction solution, in an ice bath, over 15 min and
1.0 M aq HCl was added until the pH of the solution reached to
4.0. The reaction mixture was concentrated in vacuo, and H2O
(10 mL) was added to dissolve the residue. The product was
extracted from the aqueous layer with chloroform (20 mL ꢁ 2),
and the combined organic layer was washed with brine (5 mL)
and dried over Na2SO4. The organic layer was concentrated in
vacuo, and the solid residue (826 mg) was purified by silica-gel
column chromatography using a mixture of AcOH, hexane, and
EtOAc (1:40:60, v=v=v) as an eluent to give 223 mg (36%) of
Val–Ala–Val–Phe–Val–Gly(1-13C)–Cys–OMe (16). To a stir-
red solution of peptide thioester 15, which was obtained by lyo-
philizing the elution at 17.5 min (Fig. 9B), in 100 mL of a mixture
of 0.1 M Tris-tricine buffer (pH 8.2), containing 6 M guanidine and
0.02 M TCEP, and acetonitrile (1:1, v=v) was added Cys–OMe
ꢄ
HCl (1 mg, excess). The reaction mixture was stirred for 1 h and
then subjected to RP-HPLC to give the product, peptide 16; ESI-
MS, m=z 709.3, calcd for C3213CH54N7O8S: ðM þ HÞþ 709.4.
13C NMR Spectra Measurement of Fmoc–Ile–Ala–Gly-
(1-13C)–Cys–Arg–NH2 (3) in a TFA Solution.
Fmoc–Ile–
Ala–Gly(1-13C)–Cys–Arg–NH2 (4.0 mg) was dissolved in a mix-
ture of TCEP (3.5 mg), CDCl3 (200 mL), and TFA (500 mL). The
13C NMR measurement was carried out at 300 K.
13C NMR Spectra Measurement of Fmoc–Gly(1-13C)–D,L-
(Dmmb)Ala–OMe (8) in a TFA Solution. Fmoc–Gly(1-13C)–
D,L-(Dmmb)Ala–OMe (4.2 mg) was dissolved in a mixture of
TCEP (3.5 mg), CDCl3 (100 mL), and TFA (600 mL). The 13C NMR
measurement was carried out at 300 K.